Source: Nasdaq

Moderna: Moderna Stock Falls After Resignation of FDA Official

Recently a major FDA official Peter Marks announced his resignation, heavily impacting biotech stocks such as Moderna. Wall Street is currently stressing about the future of biopharmaceutical companies and the industry as a whole. Moderna Stock Falls Marks played a significant ro

Read full article »
Annual Revenue
$1.0-5.0B
Employees
5.0-10K
Stephane Bancel's photo - Founder & CEO of Moderna

Founder & CEO

Stephane Bancel

CEO Approval Rating

61/100

Read more